Finance

Lists
Why is 301093 down 4,17%?
Dive Deeper
301093:SHE
Jiangsu Hualan New Pharmctcl Mtrl Co Ltd
CN¥54,53
-4,17%
(-2,37) 1D
14 Okt., 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301093...
Open
CN¥57,43
High
CN¥57,95
Low
CN¥54,50
Mkt. cap
12,13 mjd
Avg. vol.
5,72 m
Volume
2,62 m
Dividend
0,07%
Quarterly dividend
CN¥0,01
Ex-dividend date
16 Jul. 2026
P/E ratio
481,54
52-wk high
CN¥110,32
52-wk low
CN¥26,08
EPS
CN¥0,11
Shares outstanding
213,13 m
No. of employees
945
Open
CN¥57,43
High
CN¥57,95
Low
CN¥54,50
Mkt. cap
12,13 mjd
Avg. vol.
5,72 m
Volume
2,62 m
Dividend
0,07%
Quarterly dividend
CN¥0,01
Ex-dividend date
16 Jul. 2026
P/E ratio
481,54
52-wk high
CN¥110,32
52-wk low
CN¥26,08
EPS
CN¥0,11
Shares outstanding
213,13 m
No. of employees
945
News stories
From web sources and news partners
About Jiangsu Hualan New Pharmctcl Mtrl Co Ltd
CEO-
Employees945
Founded04 Jun. 1992
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
132,48 m
178,21 m
129,56 m
168,48 m
Cost of goods sold
80,54 m
112,49 m
81,34 m
101,28 m
Cost of revenue
80,54 m
112,49 m
81,34 m
101,28 m
Research and development expenses
11,49 m
9,97 m
11,08 m
11,84 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30,51 m
48,82 m
40,49 m
48,00 m
Operating expense
38,98 m
64,63 m
51,53 m
64,52 m
Total operating expenses
119,52 m
177,12 m
132,87 m
165,80 m
Operating income
12,96 m
1,08 m
-3,31 m
2,68 m
Other non operating income
1,15 m
-1,45 m
-1,52 m
1,25 m
EBT including unusual items
11,86 m
7,13 m
362,74 k
6,42 m
EBT excluding unusual items
12,90 m
3,28 m
-3,35 m
4,99 m
Income tax expense
2,36 m
490,19 k
58,06 k
-441,76 k
Effective tax rate
19,90%
6,88%
16,00%
-6,88%
Other operating expenses
-2,09 m
4,83 m
58,66 k
2,44 m
Net income
9,58 m
6,86 m
609,65 k
7,06 m
Net profit margin
7,23%
3,85%
0,47%
4,19%
Earnings per share
-
-
-
-
Interest and investment income
2,18 m
2,40 m
1,87 m
4,45 m
Interest expense
-490,32 k
-629,48 k
-385,97 k
-497,32 k
Net interest expenses
1,69 m
1,77 m
1,48 m
3,95 m
Depreciation and amortization charges
-
-
-
-
EBITDA
26,80 m
17,70 m
13,30 m
22,30 m
Gain or loss from assets sale
-616,30 k
541,22 k
-
169,35 k
AI content may include mistakes. Learn more
Google-programme